Benjamin J. Zeskind, President and CEO of Immuneering Corp ($IMRX), made three open market purchases of company shares in the last year, totaling about $85,000. His latest buy occurred on July 2, 2025. Among nearly 5,000 insiders tracking open market buys, Zeskind ranks 2,546th by purchase value, well below the average of $1.46 million across about 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | Immuneering Corp | $IMRX | Zeskind Benjamin J. | PRESIDENT AND CEO | A | Stock Option | 688000 | $0.00 | 688,000.0000 | 64,569,967 | 9999.99% | 1.07% |
| July 2, 2025 | Immuneering Corp | $IMRX | Zeskind Benjamin J. | PRESIDENT AND CEO | P | Class A Common Stock | 7015 | $3.53 | 3,207,779.0000 | 35,887,252 | 0.22% | 0.02% |
| July 1, 2025 | Immuneering Corp | $IMRX | Zeskind Benjamin J. | PRESIDENT AND CEO | P | Class A Common Stock | 2985 | $3.38 | 3,200,764.0000 | 35,887,252 | 0.09% | 0.01% |
| June 18, 2025 | Immuneering Corp | $IMRX | Zeskind Benjamin J. | PRESIDENT AND CEO | P | Class A Common Stock | 21000 | $2.39 | 3,197,779.0000 | 35,887,252 | 0.66% | 0.06% |
| Feb. 5, 2025 | Immuneering Corp | $IMRX | Zeskind Benjamin J. | PRESIDENT AND CEO | A | Stock Option | 480000 | $0.00 | 480,000.0000 | 0 | 9999.99% | 0.00% |
| March 19, 2024 | Immuneering Corp | $IMRX | Zeskind Benjamin J. | PRESIDENT AND CEO | P | Class A Common Stock | 20000 | $2.77 | 3,176,779.0000 | 0 | 0.63% | 0.00% |
| Feb. 8, 2024 | Immuneering Corp | $IMRX | Zeskind Benjamin J. | PRESIDENT AND CEO | A | Stock Option | 244286 | $0.00 | 244,286.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Immuneering Corp | $IMRX | Zeskind Benjamin J. | PRESIDENT AND CEO | A | Stock Option | 16414 | $0.00 | 16,414.0000 | 0 | 9999.99% | 0.00% |